There Are Now 50 Psychedelics Companies Listed In The U.S. – Here They Are
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors.
This Psychedelic Therapies Stock Has A Better One-Year Return Than Nio, AMD, Nvidia And GE
Field Trip Health Ltd (NASDAQ: FTRP) is a global leader in psychedelic therapies, and over the past year, bringing eye-popping gains to investors’ portfolios.
6 Psychedelic Stocks With Buy Rating: Why Are They Good Investments?
This article by Jason Najum was originally published on Microdose Psychedelic Insights and appears here with permission.
The psychedelic medicine industry continues to get attention and gain credibility in the investment world.
Elon Musk Acknowledges Therapeutic Potential Of Psychedelic Drugs: Will This Impact The Markets?
Elon Musk expressed his support for the therapeutic potential of psychedelic drugs.
The Space X and Tesla (NASDAQ: TSLA) CEO shared his opinion on psychedelic substances in a Q&A at the CodeCon event on Tuesday.
Meet The Top 12 CEOs In The Psychedelics Industry
By Natan Ponieman and Javier Hasse
The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate leaders, working to create new methods for the treatment of mental health and other serious conditions.
Field Trip Stock Could Climb 300% In One Year
On Wednesday, HC WainWright began coverage of Field Trip Health (NASDAQ: FTRP), a company in the psychedelics space, which is developi